Core Laboratories (NYSE:CLB) Price Target Lowered to $15.00 at Stifel Nicolaus

Core Laboratories ( NYSE:CLB – Get Free Report ) had its target price dropped by investment analysts at Stifel Nicolaus from $19.00 to $15.00 in a report released on Tuesday, Benzinga reports.

The firm presently has a “hold” rating on the oil and gas company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 21.95% from the company’s current price.



Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and increased their price objective for the company from $15.00 to $16.00 in a research note on Wednesday, March 12th.

One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. According to data from MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and an average price target of $15.

75. Check Out Our Latest Stock Analysis on Core Laboratories Core Laboratories Trading Up 2.6 % Core Laboratories ( NYSE:CLB – Get Free Report ) last issued its quarterly earnings data on Wednesday, January 29th.

The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23.

Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.

On average, research analysts anticipate that Core Laboratories will post 0.96 EPS for the current fiscal year. Institutional Trading of Core Laboratories Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock.

Confluence Investment Management LLC boosted its stake in shares of Core Laboratories by 0.4% during the 4th quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company’s stock worth $2,360,000 after purchasing an additional 599 shares during the last quarter.

Isthmus Partners LLC boosted its position in Core Laboratories by 5.6% during the fourth quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company’s stock worth $194,000 after acquiring an additional 599 shares during the last quarter.

Tidal Investments LLC grew its stake in Core Laboratories by 1.7% in the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock worth $813,000 after acquiring an additional 716 shares during the period.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Core Laboratories by 3.7% in the 4th quarter.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company’s stock worth $463,000 after acquiring an additional 960 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in Core Laboratories by 173.

8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after acquiring an additional 1,293 shares during the last quarter. Hedge funds and other institutional investors own 97.

81% of the company’s stock. About Core Laboratories ( Get Free Report ) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments.

The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. Further Reading Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter .

.